Overview
IASLC faculty members from Europe, Asia, and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on
- how COVID-19 impacts their patient population
- changes made in the management of current and newly diagnosed lung cancer patients due to pandemic, including starting and stopping treatment and monitoring
- testing for COVID-19
- outcomes of COVID-19 positive lung cancer patients.
Format: There will be two presentations followed by ample time for questions from the audience.
Date and Time: April 29, 2020 at 9:00AM EDT; 3:00PM CEST; 9:00PM HKT
Medical oncologists treating lung cancer patients, other clinical specialists involved in lung cancer care, and patients/patients advocates.
At the conclusion of this webinar, learners will have improved their ability to make treatment decisions for patients with advanced stage lung cancer during the COVID-19 pandemic.
Planning Chair:
Francisco Suarez, MD, Chile
Planning Committee Members:
Federico Cappuzzo, MD, Italy
Caicun Zhou, MD, PhD, China
Murry Wynes, PhD, United States
Chandra Belani, MD, United States
Kirsten Black, PhD, MPH, United States
For any inquiries, please contact meetings@iaslc.org.
Date and Time: April 29, 2020 at 9:00AM EDT; 3:00PM CEST; 9:00PM HKT
Medical oncologists treating lung cancer patients, other clinical specialists involved in lung cancer care, and patients/patients advocates.
At the conclusion of this webinar, learners will have improved their ability to make treatment decisions for patients with advanced stage lung cancer during the COVID-19 pandemic.
Planning Chair:
Francisco Suarez, MD, Chile
Planning Committee Members:
Federico Cappuzzo, MD, Italy
Caicun Zhou, MD, PhD, China
Murry Wynes, PhD, United States
Chandra Belani, MD, United States
Kirsten Black, PhD, MPH, United States
For any inquiries, please contact meetings@iaslc.org.
Share
Related Content
